
Ladder Therapeutics, operating as Serna Bio, is an AI-driven drug discovery company focused on developing small molecules that modulate RNA translation and splicing for challenging drug targets. By leveraging synthetic biology, machine learning, and extensive multiplex screening, they aim to address high unmet medical needs in drug discovery. Their unique approach includes the world's largest database of functional RNA structures and innovative chemical libraries, which support both internal projects and collaborations. This positions them at the forefront of RNA therapeutics, with a commitment to redefining drug discovery through data-driven insights and ambitious goals.

Ladder Therapeutics, operating as Serna Bio, is an AI-driven drug discovery company focused on developing small molecules that modulate RNA translation and splicing for challenging drug targets. By leveraging synthetic biology, machine learning, and extensive multiplex screening, they aim to address high unmet medical needs in drug discovery. Their unique approach includes the world's largest database of functional RNA structures and innovative chemical libraries, which support both internal projects and collaborations. This positions them at the forefront of RNA therapeutics, with a commitment to redefining drug discovery through data-driven insights and ambitious goals.